$JNJ Q2 2020 - Rev $18.3B (-10.8% YoY)    * Consumer Health: $3,296M (-7.0%)    * Pharmaceutical: $10,752M (+2.1%)    * Medical Devices: $4,288M (-33.9%) - Non-GAAP EPS $1.67 (-35.3% YoY)  - 2020 Guidance: Revenues: $79.9B-81.4B (from $77.5B-80.5B)